24/7 Customer Support

Talk to Clare

+1 339 368 6001

Publication dates

Antibody Industry, October 2014 Market Reports from Top Publishers

You might be interested in: Diagnostic, Flow Cytometry, Disease Testing, more »


 
1-10 of about 200 reports for Antibody

Global and China Monoclonal Antibody Industry Report, 2014-2019

Global and China Monoclonal Antibody Industry Report, 2014-2019

  • $ 2 600
  • Industry report
  • October 2014
  • by Research In China

... Global and china monoclonal antibody industry report, 2014-2019 despite world-wide economic downturn and great changes in exchange rate, benefiting from robust market demand, global monoclonal ...

Physician Views: Biosimilar Lucentis - what opportunity?

Physician Views: Biosimilar Lucentis - what opportunity?

  • $ 645
  • Industry report
  • October 2014
  • by Firstword Pharma

... Physician views: biosimilar lucentis - what opportunity With the initial focus of biosimilar antibody developers very much sharpened ...

Abnova Corporation (Symbol:4133) SWOT Analysis, Strategy, Revenues and Profits

Abnova Corporation (Symbol:4133) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Production through a genomic/proteomic approach rather than the trional method of antibody production. The company's product portfolio includes dna & rna, sirna/chimera, proteins/peptides, maxpab ab ...

Innate Pharma SA (Symbol:IPH) SWOT Analysis, Strategy, Revenues and Profits

Innate Pharma SA (Symbol:IPH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Of immunopharmacology and antibody technology. The company carries out the discovery and development of therapeutic antibodies for the treatment of cancer and inflammatory diseases. It develops new monoclonal antibodies ...

Intellect Neurosciences, Inc. (ILNS) - Financial and Strategic SWOT Analysis Review

Intellect Neurosciences, Inc. (ILNS) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Protein. The company offers small neuroprotective molecules and neoepitope-based immunotherapy approaches including, monoclonal antibodies, antibody drug conjugates and vaccines targeting beta amyloid ...

Affitech A/S (Symbol:AFFITECH) SWOT Analysis, Strategy, Revenues and Profits

Affitech A/S (Symbol:AFFITECH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Growth factors, simple receptors, carbohydrates and toxins; and cbas - cell based antibody selection technology is used to generate antibodies to multiple different g-protein coupled receptors. Affitech ...

MP Biomedicals, LLC SWOT Analysis, Strategy, Revenues and Profits

MP Biomedicals, LLC SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Chemical and diagnostic products. Its life science products include adsorbents, antibodies and immunoreagents, apoptosis, biochemicals and reagents, culture media and reagents, kits and assays, labware ...

Medy-Tox Inc. (Symbol:086900) SWOT Analysis, Strategy, Revenues and Profits

Medy-Tox Inc. (Symbol:086900) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... antibodies. It is also developing humanized antibody and therapeutic human neutralizing antibodies using antibody engineering techniques. The company exports its products to more than 50 countries including ...

Gene Techno Science Co., Ltd. (4584) - Financial and Strategic SWOT Analysis Review

Gene Techno Science Co., Ltd. (4584) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... And markets drug and antibodies for intractable diseases and rare diseases. Its products include gnd-001, gnd-002, gnd-003, gnd-004, gnd-005, gnd-006, and gnd-007. Gts' gnd-004, gnd-002 and gnd-003 is an anti ...

Nucleic Acid Aptamers for Diagnostics and Therapeutics: Global Markets

Nucleic Acid Aptamers for Diagnostics and Therapeutics: Global Markets

  • $ 6 650
  • Industry report
  • September 2014
  • by BCC Research

... This report includes key technologies involved, analyzes the capabilities and characteristics of aptamers in comparison with antibodies and lists specific areas where aptamers could find application. Forecasts ...

About 2 500 reports for Antibody

Download Unlimited Documents from Trusted Public Sources

Sanofi Annual Report 2013

  • Http www edgar online com
  • January 2013
    193 pages
  • Common Stock  

    Equity Market  

    Antibody  

  • United States  

View report >

4 Companies for Antibody

Read our Company Profiles

Biogen Idec

United States

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Synthon

Netherlands

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.